GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Additional Paid-In Capital

Valbiotis (XPAR:ALVAL) Additional Paid-In Capital : €18.23 Mil(As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Valbiotis Additional Paid-In Capital?


Valbiotis's quarterly additional paid-in capital declined from Dec. 2022 (€37.10 Mil) to Jun. 2023 (€5.60 Mil) but then increased from Jun. 2023 (€5.60 Mil) to Dec. 2023 (€18.23 Mil).

Valbiotis's annual additional paid-in capital increased from Dec. 2021 (€32.33 Mil) to Dec. 2022 (€37.10 Mil) but then declined from Dec. 2022 (€37.10 Mil) to Dec. 2023 (€18.23 Mil).

Valbiotis Additional Paid-In Capital Historical Data

The historical data trend for Valbiotis's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valbiotis Additional Paid-In Capital Chart

Valbiotis Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only 20.22 22.21 32.33 37.10 18.23

Valbiotis Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.33 28.34 37.10 5.60 18.23

Valbiotis Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Valbiotis Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Valbiotis's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Valbiotis (XPAR:ALVAL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valbiotis SA (XPAR:ALVAL) » Definitions » Additional Paid-In Capital
Comparable Companies
XPAR:MAAT XPAR:ALCLS XPAR:ALACT XPAR:OSE XPAR:ADOC XPAR:ABNX XPAR:ALGEN XPAR:GNRO XPAR:ALVIO XPAR:PHXM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
8JD:Germany
Address
12F rue Paul VATINE, Perigny, La Rochelle, FRA, 17180
Website
http://www.valbiotis.com
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Valbiotis (XPAR:ALVAL) Headlines

No Headlines